|
|
DAY 1
|
|
|
Opening session – Driving Europe’s cancer mission
|
|
|
High-level keynote session – The state-of-the-art of cancer care, research and education in Europe
|
|
|
BLOCK 1 – Prevention, early detection & diagnostics
|
|
|
Plenary session 1 – Advancing targeted prevention, early detection and precision diagnostics across Europe through EUnetCCC
|
|
|
Please select one option below:
|
|
|
Parallel session 1: From population prevention to personalised prevention: building cancer prevention hubs across European Comprehensive Cancer Centres
|
|
|
Parallel session 2: EUCCC certification: comprehensiveness starts with prevention
|
|
|
Parallel session 3: AI-powered early detection: from promising tools to trusted implementation in CCCs
|
|
|
Parallel session 4: Implementation of liquid biopsy into CCCs
|
|
|
BLOCK 2 – High-quality care: standards, integration and equity
|
|
|
Plenary session 2 – From concept to implementation of the Network: how EUnetCCC is strengthening standards, harmonising practices and reinforcing Europe’s healthcare sovereignty
|
|
|
Please select one option below:
|
|
|
Parallel session 5: From governance to benchmarking: Harmonising data practices to advance high-quality cancer care in CCCs
|
|
|
Parallel session 6: Identifying national contexts’ enablers and barriers towards successful implementation of the EU CCC Certification
|
|
|
Parallel session 7: Patient involvement in EUCCC scheme
|
|
|
Parallel session 8: Expectations for upcoming updates of the EU CCC scheme: lessons learnt from aspiring CCCs and the importance of scientific expertise
|
|
|
Please select one option below:
|
|
|
Parallel session 9: CCCNs & CCCs: Complementary Journey
|
|
|
Parallel session 10: From regional collaboration to European networks: scaling patient-centred collaboration in paediatric and AYA cancer care
|
|
|
Parallel session 11: Implementation and follow-up on clinical guidelines to reduce inequity in cancer care
|
|
|
Parallel session 12: Pilots
|
|
|
BLOCK 3 – Research, innovation & clinical trials
|
|
|
Plenary session 3 – Clinical trials and research collaboration in Europe: scaling innovation through CCCs
|
|
|
Please select one option below:
|
|
|
Parallel session 13: De-escalation in oncology: transforming clinical practice through collaboration
|
|
|
Parallel session 14: From rich data to improved patient care in European CCCs: Pan-European collaboration for AI-driven improvements across the cancer continuum
|
|
|
Parallel session 15: Empowering Europe in research and clinical trials: EUCCC certification accelerating the pace
|
|
|
Parallel session 16: From academic discovery to biotech competitiveness: the role of CCCs in Europe’s Biotech Act agenda
|
|
|
Please select one option below:
|
|
|
Parallel session 17: Engaging with the innovation ecosystem: what should industry expect from a European network of CCCs?
|
|
|
Parallel session 18: Unlocking broad consent: turning samples and data into shared knowledge in EUnetCCC
|
|
|
Parallel session 19: Joint session CANDLE/EUnetCCC
|
|
|
Parallel session 20: Boosting clinical trial activities in Europe through active networking and knowledge-exchange
|
|
|
Networking cocktail
|
|
|
DAY 2
|
|
|
BLOCK 4 – Treatment, survivorship and quality of life
|
|
|
Plenary session 4 – Turning EU cancer investments into impact
|
|
|
Plenary session 5 – Improving cancer outcomes through EUnetCCC
|
|
|
Please select one option below:
|
|
|
Parallel session 21: Living the Experience: Patient and AYA Perspectives
|
|
|
Parallel session 22: Advancing survivorship care across CCs
|
|
|
Parallel session 23: CCCs and EURACAN: structured interface for rare cancers
|
|
|
Parallel session 24: CAR T-cell therapies in practice: organising complex care pathways through Comprehensive Cancer Centres
|
|
|
BLOCK 5 – Reducing inequalities & strengthening capacities
|
|
|
Plenary session 6 – Improving equity in cancer care through capacity building & collaboration in EUnetCCC
|
|
|
Please select one option below:
|
|
|
Parallel session 25: Advancing patient-centred cancer care: From care pathways to strategic drivers
|
|
|
Parallel session 26: Supporting the certification of Consortia CCC: The challenge of organising the Care domain
|
|
|
Parallel session 27: Capacity building framework for high-quality care for CCCNs
|
|
|
Parallel session 28: Targeted support for smaller and unique healthcare environments
|
|
|
Plenary session 7 – The European network of CCCs as a strategic infrastructure for cancer in Europe
|
|
|
Plenary session 8 – From implementation to policy priorities: key recommendations from EUnetCCC. CCC perspectives & expectations on Europe’s cancer future
|
|
|
Closing session – Future vision for CCCs and cancer care in Europe (20-30 years horizon)
|